Drug Type Small molecule drug |
Synonyms AQ-4-N, AQ4N, AZD 1689 + [1] |
Target |
Mechanism Top II inhibitors(Topoisomerase II inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC22H28N4O6 |
InChIKeyYZBAXVICWUUHGG-UHFFFAOYSA-N |
CAS Registry136470-65-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma Multiforme | Phase 2 | US | 01 Oct 2006 | |
Chronic Lymphocytic Leukemia | Phase 2 | US | 01 Mar 2005 | |
Non-Hodgkin Lymphoma | Phase 2 | US | 01 Mar 2005 | |
Acute Lymphoblastic Leukemia | Phase 2 | US | - | |
Acute Lymphoblastic Leukemia | Phase 2 | - | - | |
Acute Lymphoblastic Leukemia | Phase 2 | - | - | |
Acute Lymphoblastic Leukemia | Phase 2 | - | - | |
B-Cell Lymphoma | Phase 2 | US | - | |
Glioblastoma | Phase 2 | US | - | |
Glioblastoma | Phase 2 | - | - |
Phase 1 | 16 | wiiuadnkcn(ywnilydovr) = stnncpjqbm vgmzdoqnfs (wdlcjxtgig ) | - | 20 Jun 2006 | |||
Not Applicable | - | - | AQ4 | emuscrpqhw(hrfzlgcyiw) = zmaqbwsdma gccqlwpwjq (bdmbutmgkg, 0.1) | - | 01 May 2006 |